Multiple Sclerosis

Severe COVID-19 Outcomes for MS Patients Linked to Several Factors

July 03, 2020


The results echo the previous understanding of MS specialists as well as add to the literature that has been collected thus far from other assessments.

New Agents Available for Insomnia and Multiple Sclerosis

June 09, 2020


Recent studies show efficacy and safety for both lemborexant and ozanimod.

Janssen Submits NDA for New Multiple Sclerosis Drug

March 20, 2020


Ponesimod reduced fatigue-related symptoms in phase 3 clinical trial.

Stakeholders Discuss Impact of COVID-19 on MS Patients

March 13, 2020


Hospitals are preparing to treat MS patients safely in the wake of fears over the global pandemic.

Multiple Sclerosis Relapses Worsen Cognitive Impairment

March 06, 2020


MS patients who experience relapses score significantly lower on the Timed 25-Foot Walk Test.

Trends in Spending and Pricing of Disease-Modifying Therapies for MS

August 27, 2019


A recent review of claims data from 2006-2016 revealed out-of-pocket costs for patients have increased seven-fold during the 10-year period, from $372 to $2673 annually.

Obesity and the Risk of Pediatric Multiple Sclerosis

July 15, 2019


Recent study shows that obesity appears to be associated with an increased pediatric MS risk and that obese patients did not respond well to first-line medications.

June Halper: Up and Coming Drugs in Multiple Sclerosis

July 10, 2019


What new drug classes are catching the most traction among clinicians?

June Halper: How MRIs Changed Multiple Sclerosis Care

July 07, 2019


It may not be the glitziest addition to screening tools, but MRIs have stood out as a care-changing resource.

June Halper: The Modern Doctor and Past Advances of MS Care

July 05, 2019


The role of a primary care physician in multiple sclerosis care should be minimal.